Search

everythinglearnresearchcommunity

for

Search:↓

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Androgenetic alopecia in women needs more research and better management strategies.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

FFA's causes may include environmental triggers and genetic factors.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Finasteride improves hair density and thickness in women with hair loss.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

SHBG may be a useful early indicator and treatment target for PCOS.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.